WS #4121

The data dump reveals escalating geopolitical and economic pressures with immediate market-moving implications. President Trump's threats to withdraw the US from NATO, citing lack of support for the Iran war, are corroborated by multiple sources (Financial Times, Telegraph, German media) and coincide with European allies (Spain, France, Italy) denying US military access, heightening defense sector uncertainty and alliance instability. This is compounded by a UNSC vote scheduled for Friday on a Bahrain-backed resolution to authorize force to secure the Strait of Hormuz, with Russia and China opposing explicit force language, indicating geopolitical fractures. Concurrently, the Iran conflict continues to disrupt energy and tech markets, with reports of Iranian attacks on Oracle and Amazon data centers in the UAE and Bahrain, potentially impacting cloud infrastructure stocks and oil supply chains, and Iran retaining significant missile capability despite US-Israel strikes. Domestically, Trump's cabinet reshuffle continues with the firing of Attorney General Pam Bondi, linked to dissatisfaction over Epstein files handling, signaling potential DOJ policy shifts, with reports of further potential dismissals (FBI head, Army Secretary). Economic signals include Trump imposing new tariffs on pharmaceuticals (up to 100%) and revising metal tariffs (25% on finished goods), effective Monday for metals and 120-180 days for drugs, with exceptions for allies like EU and Japan, directly affecting pharmaceutical and industrial sectors. India's abolition of import duties on 40 petrochemicals until June 2026 aims to support domestic industries amid supply chain disruptions from the Iran war, impacting global chemical markets. Tesla reports Q1 2026 sales up 6% but below expectations, with shares falling 3%, reflecting ongoing challenges from the Elon Musk boycott and increased EV competition. These developments point to heightened volatility in defense, energy, and pharmaceutical stocks, with specific attention to NATO-related defense contractors, oil majors, and pharmaceutical companies exposed to US tariffs.